网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
帕瑞昔布钠不同给药方式对乳腺癌改良根治术患者术后吗啡用量的影响
作者:高嵩 田文华 李建军 
单位:湖北省武汉市汉口医院麻醉科
关键词:帕瑞昔布钠 乳腺癌改良根治术 吗啡 超前镇痛 自控镇痛(PCA) 
分类号:
出版年·卷·期(页码):2012·40·第四期(420-423)
摘要:

摘要 目的:观察帕瑞昔布钠不同给药方式对乳腺癌改良根治术患者术后吗啡镇痛的影响。方法:择期行乳腺癌改良根治术患者60例,年龄45~69岁,ASA I~ Ⅱ级,随机分为2组(n=30):A组(帕瑞昔布钠超前镇痛组)和B组(帕瑞昔布钠常规镇痛组)。静脉注射咪达唑仑、丙泊酚、舒芬太尼、维库溴铵麻醉诱导,吸入七氟烷,间断给予舒芬太尼或维库溴铵维持麻醉。A组切皮前15 min静脉注射首剂帕瑞昔布钠40 mg和手术结束前30min静脉注射0.9%氯化钠注射液2ml及间隔12h后静脉注射帕瑞昔布钠40 mg,B组切皮前15 min静脉注射0.9%氯化钠注射液2ml和手术结束前30min静脉首剂帕瑞昔布钠40 mg及间隔12h后静脉注射帕瑞昔布钠40 mg。术毕两组患者均采用吗啡患者自控镇痛(PCIA)。记录术后2、4、 8、12、24 h的视觉模拟评分(VAS)、24h按压总次数和有效按压次数、术后24 h吗啡用量和不良反应发生情况。结果:与B组比较,A组术后各时点VAS评分差异均无统计学意义,24h总按压次数和有效按压次数均明显减少,术后24 h吗啡用量减少(P<0.05),两组患者术后不良反应无明显差异(P>0.05)。结论:帕瑞昔布联合吗啡多模式超前镇痛对乳腺癌改良根治术患者术后镇痛,可减少吗啡用量,有利于患者恢复。

【Abstract Objective】 Objective To observe the effects of parecoxib sodium of different delivery ways of modified radical mastectomy of breast cancer patients with postoperative morphine analgesia effect. Methods Undergoing modified radical mastectomy of breast cancer patients with 60 cases, aged 45 to 69 years old, ASA I - II, were randomly divided into 2 groups ( n = 30 ) : A group ( preemptive analgesia effects of parecoxib group ) and group B ( parecoxib conventional analgesia group ). Intravenous midazolam, propofol, sufentanil, vecuronium bromide inhalation induction of anesthesia, seven halothane, interrupted administration of sufentanil or vecuronium maintenance of anesthesia. A group before skin incision of 15 intravenous injection of Min first dose of parecoxib sodium 40 mg and 30min operation before the end of the intravenous injection of 0.9% sodium chloride injection of 2ml and 12h interval after intravenous parecoxib sodium 40 mg, group B before skin incision of 15 min intravenous injection of 0.9% sodium chloride injection and operation before the end of the vein of 30min 2ml the first agent of parecoxib sodium 40 mg and 12h interval after intravenous parecoxib sodium 40 mg. After operation two patients were with morphine patient-controlled analgesia ( PCIA ). Recorded after 2, 4, 8, 12, 24 h visual analogue scale ( VAS ), the total number of 24h press and press times, after 24 h morphine consumption and the occurrence of adverse reactions. Results Compared with B group, A group after each time VAS scores showed no significant differences in total, 24h press times and effective pressing significantly reduce the number of times, after 24 h of morphine dosage reduction ( P < 0.05 ), the two groups of patients with adverse reaction of no significant difference ( P > 0.05 ). Conclusion Parecoxib combined with morphine of preemptive analgesia on modified radical mastectomy of breast cancer patients with postoperative analgesia, can reduce the morphine

参考文献:
服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 759824 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541